União Europeia - islandês - EMA (European Medicines Agency)

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Æxlishemjandi lyf - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.

União Europeia - islandês - EMA (European Medicines Agency)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hinsveiflur og heilahimnubólur og hliðstæður - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - furosemidum inn - tafla - 40 mg

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - furosemidum inn - tafla - 20 mg

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - bleomycinum súlfat - stungulyfs-/innrennslisstofn, lausn - 15.000 a.e.

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - paclitaxelum inn - innrennslisþykkni, lausn - 6 mg/ml

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

mcneil denmark aps - diphenhydraminum hýdróklóríð - mixtúra, lausn - 1,4 mg/ml

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

mcneil denmark aps - diphenhydraminum hýdróklóríð - mixtúra, lausn - 2,8 mg/ml

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - vinorelbinum tvítartrat - innrennslisþykkni, lausn - 10 mg/ml

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - methotrexatum inn - tafla - 2,5 mg